| 0.4 |
1.8 |
GO:0007614 |
short-term memory(GO:0007614) |
| 0.3 |
0.8 |
GO:0048389 |
intermediate mesoderm development(GO:0048389) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) bud dilation involved in lung branching(GO:0060503) branch elongation involved in ureteric bud branching(GO:0060681) regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) pulmonary artery morphogenesis(GO:0061156) cell proliferation involved in mesonephros development(GO:0061209) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) negative regulation of mesonephros development(GO:0061218) pattern specification involved in mesonephros development(GO:0061227) renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) BMP signaling pathway involved in nephric duct formation(GO:0071893) glomerular visceral epithelial cell development(GO:0072015) comma-shaped body morphogenesis(GO:0072049) regulation of branch elongation involved in ureteric bud branching(GO:0072095) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in kidney development(GO:0072098) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) glomerulus morphogenesis(GO:0072102) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) nephric duct formation(GO:0072179) ureter urothelium development(GO:0072190) ureter epithelial cell differentiation(GO:0072192) ureter morphogenesis(GO:0072197) metanephric comma-shaped body morphogenesis(GO:0072278) glomerular epithelial cell development(GO:0072310) negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
| 0.2 |
2.5 |
GO:0051918 |
negative regulation of fibrinolysis(GO:0051918) |
| 0.2 |
0.7 |
GO:0016554 |
cytidine to uridine editing(GO:0016554) |
| 0.2 |
1.1 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.2 |
1.5 |
GO:0006553 |
lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
| 0.2 |
1.2 |
GO:0060414 |
aorta development(GO:0035904) aorta morphogenesis(GO:0035909) aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.2 |
0.7 |
GO:0008065 |
establishment of blood-nerve barrier(GO:0008065) |
| 0.1 |
1.6 |
GO:0051497 |
negative regulation of stress fiber assembly(GO:0051497) |
| 0.1 |
0.6 |
GO:0051503 |
purine ribonucleotide transport(GO:0015868) adenine nucleotide transport(GO:0051503) |
| 0.1 |
0.4 |
GO:0060318 |
definitive erythrocyte differentiation(GO:0060318) |
| 0.1 |
0.3 |
GO:0019731 |
antibacterial humoral response(GO:0019731) |
| 0.1 |
0.6 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.1 |
0.8 |
GO:0042693 |
muscle cell fate commitment(GO:0042693) |
| 0.1 |
0.5 |
GO:0008628 |
hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 0.1 |
0.3 |
GO:0030205 |
dermatan sulfate metabolic process(GO:0030205) dermatan sulfate biosynthetic process(GO:0030208) |
| 0.1 |
0.6 |
GO:0006264 |
mitochondrial DNA replication(GO:0006264) |
| 0.1 |
0.5 |
GO:0030210 |
heparin biosynthetic process(GO:0030210) |
| 0.1 |
0.3 |
GO:0031034 |
skeletal muscle myosin thick filament assembly(GO:0030241) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
| 0.1 |
0.9 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.1 |
1.7 |
GO:0070206 |
protein trimerization(GO:0070206) |
| 0.1 |
0.5 |
GO:0060242 |
contact inhibition(GO:0060242) |
| 0.1 |
0.7 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.1 |
0.6 |
GO:0042448 |
progesterone metabolic process(GO:0042448) |
| 0.1 |
0.3 |
GO:0051541 |
elastin metabolic process(GO:0051541) |
| 0.1 |
0.2 |
GO:0051097 |
negative regulation of helicase activity(GO:0051097) cellular response to exogenous dsRNA(GO:0071360) |
| 0.1 |
3.5 |
GO:0006749 |
glutathione metabolic process(GO:0006749) |
| 0.1 |
0.5 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
| 0.1 |
0.5 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.1 |
0.6 |
GO:0090292 |
nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.1 |
0.3 |
GO:0006515 |
misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
| 0.1 |
5.1 |
GO:0007498 |
mesoderm development(GO:0007498) |
| 0.0 |
0.2 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.0 |
0.8 |
GO:0006071 |
glycerol metabolic process(GO:0006071) |
| 0.0 |
0.1 |
GO:0030859 |
polarized epithelial cell differentiation(GO:0030859) establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.0 |
0.6 |
GO:1901797 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
| 0.0 |
1.1 |
GO:0031000 |
response to caffeine(GO:0031000) |
| 0.0 |
2.6 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.0 |
0.1 |
GO:0035461 |
vitamin transmembrane transport(GO:0035461) |
| 0.0 |
1.4 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.0 |
1.1 |
GO:0051923 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) sulfation(GO:0051923) |
| 0.0 |
3.4 |
GO:0019882 |
antigen processing and presentation(GO:0019882) |
| 0.0 |
0.9 |
GO:0008347 |
glial cell migration(GO:0008347) |
| 0.0 |
0.1 |
GO:0070365 |
hepatocyte differentiation(GO:0070365) cellular response to oleic acid(GO:0071400) |
| 0.0 |
0.1 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.0 |
0.3 |
GO:0033089 |
positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.0 |
0.1 |
GO:0046520 |
diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 0.0 |
0.1 |
GO:0045356 |
positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
| 0.0 |
0.6 |
GO:0034199 |
activation of protein kinase A activity(GO:0034199) |
| 0.0 |
0.2 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.0 |
0.2 |
GO:0070779 |
D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.0 |
1.1 |
GO:0007026 |
negative regulation of microtubule depolymerization(GO:0007026) |
| 0.0 |
0.6 |
GO:0030199 |
collagen fibril organization(GO:0030199) |
| 0.0 |
0.3 |
GO:0035024 |
negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.0 |
0.1 |
GO:0051917 |
regulation of fibrinolysis(GO:0051917) |
| 0.0 |
0.1 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.0 |
0.7 |
GO:0006693 |
prostaglandin metabolic process(GO:0006693) |
| 0.0 |
0.1 |
GO:0002903 |
negative regulation of B cell apoptotic process(GO:0002903) |
| 0.0 |
0.3 |
GO:0007566 |
embryo implantation(GO:0007566) |
| 0.0 |
0.3 |
GO:0007584 |
response to nutrient(GO:0007584) |
| 0.0 |
0.3 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.0 |
0.1 |
GO:0032007 |
negative regulation of TOR signaling(GO:0032007) |
| 0.0 |
2.2 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.0 |
0.3 |
GO:0051319 |
mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
| 0.0 |
0.3 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.0 |
0.3 |
GO:0071230 |
cellular response to amino acid stimulus(GO:0071230) |
| 0.0 |
1.5 |
GO:0008360 |
regulation of cell shape(GO:0008360) |
| 0.0 |
0.6 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.0 |
1.3 |
GO:0007519 |
skeletal muscle tissue development(GO:0007519) |
| 0.0 |
0.1 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.0 |
0.1 |
GO:0010507 |
negative regulation of autophagy(GO:0010507) |
| 0.0 |
0.1 |
GO:0045898 |
regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.0 |
0.1 |
GO:0006537 |
glutamate biosynthetic process(GO:0006537) proline catabolic process(GO:0006562) |
| 0.0 |
0.1 |
GO:0060164 |
regulation of timing of neuron differentiation(GO:0060164) |
| 0.0 |
0.4 |
GO:0007586 |
digestion(GO:0007586) |
| 0.0 |
0.2 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.0 |
0.5 |
GO:0042475 |
odontogenesis of dentin-containing tooth(GO:0042475) |
| 0.0 |
0.7 |
GO:0043484 |
regulation of RNA splicing(GO:0043484) |
| 0.0 |
0.1 |
GO:0001514 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.0 |
0.6 |
GO:0042384 |
cilium assembly(GO:0042384) |
| 0.0 |
0.1 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.0 |
0.1 |
GO:0046627 |
negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
| 0.0 |
0.1 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.0 |
0.2 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.0 |
0.1 |
GO:1901998 |
tetracycline transport(GO:0015904) antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
| 0.0 |
0.7 |
GO:0050821 |
protein stabilization(GO:0050821) |
| 0.0 |
0.2 |
GO:0042036 |
negative regulation of cytokine biosynthetic process(GO:0042036) |
| 0.0 |
0.1 |
GO:0019627 |
urea metabolic process(GO:0019627) |
| 0.0 |
0.1 |
GO:0030813 |
positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) positive regulation of ATP metabolic process(GO:1903580) |
